Tomin Tamara, Bordag Natalie, Zügner Elmar, Al-Baghdadi Abdullah, Schinagl Maximilian, Birner-Gruenberger Ruth, Schittmayer Matthias
Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Technische Universität Wien, 1060 Vienna, Austria.
Center for Biomarker Research in Medicine, CBmed GmbH, 8010 Graz, Austria.
Antioxidants (Basel). 2021 May 27;10(6):864. doi: 10.3390/antiox10060864.
Timely centrifugation of blood for plasma preparation is a key step to ensure high plasma quality for analytics. Delays during preparation can significantly influence readouts of key clinical parameters. However, in a routine clinical environment, a strictly controlled timeline is often not feasible. The next best approach is to control for sample preparation delays by a marker that provides a readout of the time-dependent degradation of the sample. In this study, we explored the usefulness of glutathione status as potential marker of plasma preparation delay. As the concentration of glutathione in erythrocytes is at least two orders of magnitude higher than in plasma, even the slightest leakage of glutathione from the cells can be readily observed. Over the 3 h observation period employed in this study, we observed a linear increase of plasma concentrations of both reduced (GSH) and oxidized glutathione (GSSG). Artificial oxidation of GSH is prevented by rapid alkylation with N-ethylmaleimide directly in the blood sampling vessel as recently published. The observed relative leakage of GSH was significantly higher than that of GSSG. A direct comparison with plasma lactate dehydrogenase activity, a widely employed hemolysis marker, clearly demonstrated the superiority of our approach for quality control. Moreover, we show that the addition of the thiol alkylating reagent NEM directly to the blood tubes does not influence downstream analysis of other clinical parameters. In conclusion, we report that GSH gives an excellent readout of the duration of plasma preparation and the associated pre-analytical errors.
及时对血液进行离心以制备血浆是确保高质量血浆用于分析的关键步骤。制备过程中的延迟会显著影响关键临床参数的读数。然而,在常规临床环境中,严格控制时间线往往不可行。次优方法是通过一个能够读出样本随时间降解情况的标志物来控制样本制备延迟。在本研究中,我们探讨了谷胱甘肽状态作为血浆制备延迟潜在标志物的有用性。由于红细胞中谷胱甘肽的浓度比血浆中至少高两个数量级,即使谷胱甘肽从细胞中最轻微的泄漏也能很容易被观察到。在本研究采用的3小时观察期内,我们观察到还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)的血浆浓度呈线性增加。如最近所发表的,通过在采血容器中直接用N - 乙基马来酰亚胺快速烷基化可防止GSH的人工氧化。观察到的GSH相对泄漏明显高于GSSG。与广泛使用的溶血标志物血浆乳酸脱氢酶活性的直接比较清楚地证明了我们方法在质量控制方面的优越性。此外,我们表明将硫醇烷基化试剂NEM直接添加到血样管中不会影响其他临床参数的下游分析。总之,我们报告GSH能很好地读出血浆制备的持续时间以及相关的分析前误差。